This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Q2 revenue rises 36.6%; margins contract and half-year cash flow is negative
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.7 pts more than Nifty Microcap 250 and 1.9 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
In the standalone quarter ended 30 September 2026, revenue from operations rose 36.6% to Rs 23,048.07 lakh from Rs 16,869.03 lakh a year earlier, while profit after tax rose 10.8% to Rs 1,902.79 lakh from Rs 1,717.94 lakh. Margin for profit before interest, tax, depreciation and amortisation fell to about 11.8% of revenue from about 16.5%. Half-year operating cash flow was negative Rs 3,092.92 lakh. Prior figures were reclassified.
Revenue growth supports sentiment, but lower margins and negative operating cash flow may weigh on the stock despite higher profit.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹230.5 Cr | ₹168.7 Cr | +36.6% |
| Operating profit | ₹20.55 Cr | ₹22.05 Cr | −6.8% |
| Profit after tax | ₹19.03 Cr | ₹17.18 Cr | +10.8% |
| EBITDA margin | 11.8% | 15.9% | −4.1 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.